Use of NovoSeven® in Active Variceal Bleeding

Clinical trial NCT00154492 · COMPLETED

Trial details

NCT number: NCT00154492
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Cirrhosis

Start date: 2004-04-01
Primary completion: 2006-08-01
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.